Head-To-Head Contrast: Addus Homecare (ADUS) & Wound Management Technologies (WNDM)

Share on StockTwits

Addus Homecare (NASDAQ:ADUS) and Wound Management Technologies (OTCMKTS:WNDM) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, dividends, risk, valuation and profitability.

Analyst Recommendations

This is a summary of recent recommendations and price targets for Addus Homecare and Wound Management Technologies, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Addus Homecare 0 0 7 0 3.00
Wound Management Technologies 0 0 0 0 N/A

Addus Homecare currently has a consensus price target of $76.86, suggesting a potential upside of 16.08%. Given Addus Homecare’s higher probable upside, equities research analysts plainly believe Addus Homecare is more favorable than Wound Management Technologies.

Insider and Institutional Ownership

95.2% of Addus Homecare shares are owned by institutional investors. 34.8% of Addus Homecare shares are owned by company insiders. Comparatively, 9.6% of Wound Management Technologies shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Volatility & Risk

Addus Homecare has a beta of -0.2, indicating that its share price is 120% less volatile than the S&P 500. Comparatively, Wound Management Technologies has a beta of 2.02, indicating that its share price is 102% more volatile than the S&P 500.

Profitability

This table compares Addus Homecare and Wound Management Technologies’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Addus Homecare 3.38% 9.22% 5.99%
Wound Management Technologies 1.79% 12.58% 5.17%

Earnings & Valuation

This table compares Addus Homecare and Wound Management Technologies’ top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Addus Homecare $518.12 million 1.67 $17.50 million $1.69 39.18
Wound Management Technologies $6.30 million 2.29 $330,000.00 N/A N/A

Addus Homecare has higher revenue and earnings than Wound Management Technologies.

Summary

Addus Homecare beats Wound Management Technologies on 8 of the 11 factors compared between the two stocks.

About Addus Homecare

Addus HomeCare Corporation provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company's personal care services offer assistance with activities of daily living. Its services include assistance with bathing, grooming, oral care, assistance with feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services, as well as other activities of daily living. The company's payor clients include federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. As of December 31, 2017, the company served consumers through 116 offices located in 24 states. Addus HomeCare Corporation was founded in 1979 and is based in Frisco, Texas.

About Wound Management Technologies

WNDM Medical Inc. develops, markets, and distributes biotechnology products to physicians, hospitals, and clinics in the United States. The company offers HemaQuell, a resorbable bone hemostat for bone healing; and CellerateRX surgical for healing. The company was formerly known as Wound Management Technologies, Inc. and changed its name to WNDM Medical Inc. in April 2017. WNDM Medical Inc. was founded in 1982 and is based in Fort Worth, Texas.

Receive News & Ratings for Addus Homecare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus Homecare and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Inpixon  Sees Strong Trading Volume
Inpixon Sees Strong Trading Volume
-$0.21 Earnings Per Share Expected for Axovant Sciences Ltd  This Quarter
-$0.21 Earnings Per Share Expected for Axovant Sciences Ltd This Quarter
WandX Price Down 8.5% Over Last Week
WandX Price Down 8.5% Over Last Week
Twilio Inc  General Counsel Sells $3,074,866.60 in Stock
Twilio Inc General Counsel Sells $3,074,866.60 in Stock
Lam Research  Updates Q4 2019 Earnings Guidance
Lam Research Updates Q4 2019 Earnings Guidance
Zacks: Brokerages Anticipate Reata Pharmaceuticals Inc  to Announce -$0.97 Earnings Per Share
Zacks: Brokerages Anticipate Reata Pharmaceuticals Inc to Announce -$0.97 Earnings Per Share


© 2006-2019 Ticker Report